[EN] PURINE NUCLEOSIDE MONOPHOSPHATE PRODRUGS FOR TREATMENT OF CANCER AND VIRAL INFECTIONS<br/>[FR] PROMÉDICAMENTS À BASE DE PURINE NUCLÉOSIDE MONOPHOSPHATE POUR LE TRAITEMENT DU CANCER ET DES INFECTIONS VIRALES
申请人:RFS PHARMA LLC
公开号:WO2010091386A2
公开(公告)日:2010-08-12
The present invention is directed to compounds, compositions and methods for treating or preventing cancer and viral infections, in particular, HIV, HCV, Norovirus, Saporo virus, HSV-I, HSV-2, Dengue virus, Yellow fever, and HBV in human patients or other animal hosts. The compounds are certain 6-substituted purine monophosphates, and pharmaceutically acceptable, salts, prodrugs, and other derivatives thereof. In particular, the compounds show potent antiviral activity against HIV-I, HIV-2, HCV, Norovirus, Saporovirus, HSV-I, HSV-2, Dengue virus, Yellow fever, and HBV.